Botox is not just for banishing wrinkles from the faces of Hollywood celebrities anymore. Injections of the botulism derivative, which have also been used to treat migraines and stop profuse sweating, has recently been approved by the FDA for the treatment of overactive bladder.
Overactive bladder is a condition which occurs when the bladder squeezes too often or without warning. Often common in women who’ve had babies or after menopause; its symptoms include leaking urine and feeling the sudden and frequent urge to urinate.
In a statement announcing its approval of Botox as a treatment for the disorder the FDA noted that clinical studies have found that when the drug is injected into the bladder muscle, it causes it to relax, increasing storage capacity and reducing episodes of incontinence.
When Botox is injected into the bladder muscle, it causes the bladder to relax, increasing the its storage capacity and reducing episodes of urinary incontinence. Injecting the bladder with Botox is performed using cystoscopy, a procedure that allows the doctors to visual the bladder interior during the injection process.